Label: LIDOPRO- capsaicin, lidocaine, menthol, and methyl salicylate ointment

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated March 15, 2023

If you are a consumer or patient please visit this version.

  • Active Ingredient

    Capsaicin 0.0325%

  • Purpose

    Counterirritant

  • Active Ingredient

    Lidocaine HCL 4%

  • Purpose

    Topical Anesthetic

  • Active Ingredient

    Menthol 10%

  • Purpose

    Topical Analgesic

  • Active Ingredient

    Methyl Salicylate 27.5%

  • Purpose

    Counterirritant

  • Uses

    For the temporary relief of joint pain and muscle pain associated with:

    Arthritis
    Simple Backache
    Muscle Sprains
    Muscle Strains
  • Warnings

    For External Use Only

    Do Not Use

    On damaged, irritated, or infected skin
    With a bandage or heating pad
    If you are allergic to any ingredients in this product

    When Using This Product:

    Avoid contact with eyes and mucus membranes

    Stop Use and Ask a Doctor If:

    Conditions worsens
    Excessive skin irritation develops
    Symptoms persist for more than 7 days, or symptoms clear up and occur again within 3 days

    If Pregnant orBreast-Feeding:

    Ask a health professional before use.

    Keep Out of Reach of Children:

    If ingested seek medical help or contact a Poison Control Center immediately

    Flammable:

    Keep away from excessive heat or open flame

  • Directions

    Adults and Children 12 Years of Age and Older:

    Clean and dry the affected area
    Apply product directly to your skin, up to 4 times daily affected area
    Wash hands immediately after use

    Children Under 12 Years of Age: Consult physician

  • Other Information

    Store in a cool, dry place with lid tightly closed
    If the tamper-evident foil seal is not intact, do not use
  • Inactive Ingredients

    Allantoin, Aloe Barbadensis Leaf Juice, Ammonium Acryloyldimethyltaurate/VP Copolymer, Cetyl Alcohol, Chamomilla Recutita Matricaria Flower Extract, Dimethicone, Disodium EDTA, Ethylhexylglycerin, Glycerin, Glyceryl Stearate, Inulin Lauryl Carbamate, PEG-100 Stearate, Phenoxyethanol, Stearic Acid, Triethanolamine, Water.

  • Questions or Comments?

    info@terrainrx.com

    Relabeled By: Preferred Pharmaceuticals Inc.

  • Principal Display Panel

    NDC 53225-1020-1

    Preferred Pharmaceuticals Inc. NDC 68788-8314-1

    Schematic

Description automatically generated with medium confidence
  • INGREDIENTS AND APPEARANCE
    LIDOPRO 
    capsaicin, lidocaine, menthol, and methyl salicylate ointment
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68788-8314(NDC:53225-1020)
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CAPSAICIN (UNII: S07O44R1ZM) (CAPSAICIN - UNII:S07O44R1ZM) CAPSAICIN0.000325 g  in 1 g
    LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS0.04 g  in 1 g
    MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL, UNSPECIFIED FORM0.1 g  in 1 g
    METHYL SALICYLATE (UNII: LAV5U5022Y) (SALICYLIC ACID - UNII:O414PZ4LPZ) METHYL SALICYLATE0.275 g  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    INULIN (UNII: JOS53KRJ01)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    ALLANTOIN (UNII: 344S277G0Z)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER (UNII: W59H9296ZG)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    CHAMOMILE (UNII: FGL3685T2X)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    PEG-100 STEARATE (UNII: YD01N1999R)  
    TROLAMINE (UNII: 9O3K93S3TK)  
    WATER (UNII: 059QF0KO0R)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:68788-8314-192 g in 1 BOTTLE; Type 0: Not a Combination Product07/08/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart34807/08/2022
    Labeler - Preferred Pharmaceuticals Inc. (791119022)
    Registrant - Preferred Pharmaceuticals Inc. (791119022)
    Establishment
    NameAddressID/FEIBusiness Operations
    Preferred Pharmaceuticals Inc.791119022RELABEL(68788-8314)